Reviews, Research Highlights and Commentaries
Read the latest reviews covering advances in cancer biology and treatment across BMC flagship journals.
Second-line treatment for advanced NSCLC without actionable mutations: is immunotherapy the ‘panacea’ for all patients?
Published in BMC Medicine on: 16 February 2018
Nothing in cancer makes sense except…
Published in BMC Biology on: 21 February 2018
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
Leanne G. Ahronian and Ryan B. Corcoran
Published in Genome Medicine on: 21 April 2017
Timing somatic events in the evolution of cancer
Clemency Jolly and Peter Van Loo
Published in Genome Biology on: 24 July 2018
Aims and scope
Genome Medicine publishes research and reviews that describe important advances in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. Areas covered include, but are not limited to: precision medicine, novel methods and software, cancer genomics, disease genomics and epigenomics, immunogenomics, infectious disease, microbiome and systems medicine.
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
Genomics of infection and immunity
Guest editors: Bali Pulendran and Mark Davis
Guest editors: Joseph Buxbaum and Catalina Betancur
Highlights from infectious disease genomics
From the blog
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
In response to the current outbreak of Ebola in DR Congo, Genome Medicine editors will treat relevant submissions with priority.
Genome Medicine is now accepting co-submissions with Genome Biology and BMC Biology. Please see here for more information.